2-[(S)-cyclobutylsulfinyl]-6-[2-(4-methylpiperazin-1-yl)pyrimidin-5-yl]-4-phenylthieno[2,3-b]pyridin-3-amine
C26H28N6OS2 — CID 167341563
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(S)-cyclobutylsulfinyl]-6-[2-(4-methylpiperazin-1-yl)pyrimidin-5-yl]-4-phenylthieno[2,3-b]pyridin-3-amine
2-[(S)-cyclobutylsulfinyl]-6-[2-(4-methylpiperazin-1-yl)pyrimidin-5-yl]-4-phenylthieno[2,3-b]pyridin-3-amine (PubChem CID 167341563) has the molecular formula C26H28N6OS2 and a molecular weight of 504.69 g/mol. Its IUPAC name is 2-[(S)-cyclobutylsulfinyl]-6-[2-(4-methylpiperazin-1-yl)pyrimidin-5-yl]-4-phenylthieno[2,3-b]pyridin-3-amine.
Molecular Properties
| Compound Name | 2-[(S)-cyclobutylsulfinyl]-6-[2-(4-methylpiperazin-1-yl)pyrimidin-5-yl]-4-phenylthieno[2,3-b]pyridin-3-amine |
|---|---|
| PubChem CID | 167341563 |
| Molecular Formula | C26H28N6OS2 |
| Molecular Weight | 504.69 g/mol |
| Exact Mass | 504.18 |
| IUPAC Name | 2-[(S)-cyclobutylsulfinyl]-6-[2-(4-methylpiperazin-1-yl)pyrimidin-5-yl]-4-phenylthieno[2,3-b]pyridin-3-amine |
| SMILES | CN1CCN(c2ncc(-c3cc(-c4ccccc4)c4c(N)c([S@@](=O)C5CCC5)sc4n3)cn2)CC1 |
| InChI | InChI=1S/C26H28N6OS2/c1-31-10-12-32(13-11-31)26-28-15-18(16-29-26)21-14-20(17-6-3-2-4-7-17)22-23(27)25(34-24(22)30-21)35(33)19-8-5-9-19/h2-4,6-7,14-16,19H,5,8-13,27H2,1H3/t35-/m0/s1 |
| InChIKey | QFODMRWKGKPUKR-DHUJRADRSA-N |
| XLogP | 4.41 |
| TPSA | 88.24 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 504.69 |
| LogP ≤ 5 | 4.41 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167341563 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.